MedTrace Logo

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema

NCT03385382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-01-02

No results posted yet for this study

Summary

Between December 2016 and June 2017 a total of 40 eyes from 40 diabetic retinopathy patients with diabetic macular edema were recruited at the Ophthalmologic Clinic of University "G. d'Annunzio", Chieti-Pescara, Italy.

Conditions

Interventions

DRUG

Dexamethasone intravitreal implant 0.7 mg

Intravitreal Implant of dexamethasone

DRUG

Ranibizumab Injection

Injection of ranibizumab

Sponsors & Collaborators

  • G. d'Annunzio University

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-06
Primary Completion
2017-06-27
Completion
2017-06-27

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385382 on ClinicalTrials.gov